Toxic Epidermal Necrolysis: A Case Report to Oral Acyclovir
Abstract
SJS/TEN is a rare, potentially life threatening, immune-complex-mediated cutaneous adverse drug reaction. Almost one-third of cases are idiopathic. This syndrome is associated with drug treatment as well as infectious agents, neoplasia, and connective tissue diseases. Here we report a 36-year-old male presenting with toxic epidermal necrolysis after 2 days of oral acyclovir.
Keywords: Toxic epidermal necrolysis; Stevens-Johnson Syndrome; acyclovir
Keywords:
Toxic epidermal necrolysis, Stevens-Johnson Syndrome, acyclovirDOI
https://doi.org/10.22270/jddt.v14i4.6508References
Sen SS, Sil A, Chakraborty U, Chandra A. Stevens-Johnson syndrome-toxic epidermal necrolysis: a fatal cutaneous adverse reaction to oral acyclovir. BMJ Case Rep. 2020 Aug 26;13(8): e238555. https://doi.org/10.1136/bcr-2020-238555 PMid:32847898 PMCid:PMC7451950
Yang MS, Lee JY, Kim J, Kim GW, Kim BK, Kim JY, Park HW, Cho SH, Min KU, Kang HR. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLoS One. 2016 Nov 11;11(11): e0165933. https://doi.org/10.1371/journal.pone.0165933 PMid:27835661 PMCid:PMC5106005
Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008 Dec;14(12):1343-50. https://doi.org/10.1038/nm.1884 PMid:19029983
Bianchine JR, Macaraeg PV Jr, Lasagna L, Azarnoff DL, Brunk SF, Hvidberg EF, Owen JA Jr. Drugs as etiologic factors in the Stevens-Johnson syndrome. Am J Med. 1968 Mar;44(3):390-405. https://doi.org/10.1016/0002-9343(68)90110-1 PMid:5641302
Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol. 2017 Jun;137(6):1240-1247. https://doi.org/10.1016/j.jid.2017.01.031 PMid:28202399
Published
Abstract Display: 224 
PDF Downloads: 240 PDF Downloads: 17 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.